Hideyuki Muramatsu

Title: Innovations of Hideyuki Muramatsu

Introduction

Hideyuki Muramatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of melanocortin receptors. With a total of 5 patents to his name, Muramatsu's work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents is for Compound WS 727713. This compound is described as a new modulator of melanocortin receptors. The invention details a process for producing the compound by culturing a WS727713-producing strain in a culture medium and recovering the compound from the culture broth. Additionally, the patent outlines a pharmaceutical composition containing the compound and its various uses, including treatment for ischemia/reperfusion injury, inflammatory diseases, and obesity, among others.

Career Highlights

Throughout his career, Muramatsu has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Telsar Pharma Inc. His work in these organizations has contributed to advancements in drug development and therapeutic applications.

Collaborations

Muramatsu has collaborated with several professionals in his field, including Shigehiro Takase and Michizane Hashimoto. These collaborations have likely enhanced the scope and impact of his research and innovations.

Conclusion

Hideyuki Muramatsu's contributions to the field of pharmaceuticals, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.